PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $96,000 | -37.3% | 33,483 | -33.6% | 0.00% | – |
| Q4 2021 | $153,000 | -51.0% | 50,445 | +13.2% | 0.00% | – |
| Q3 2021 | $312,000 | -24.3% | 44,562 | -0.7% | 0.00% | – |
| Q2 2021 | $412,000 | -52.8% | 44,894 | -49.9% | 0.00% | -100.0% |
| Q1 2021 | $872,000 | +2.6% | 89,683 | +8.2% | 0.00% | 0.0% |
| Q4 2020 | $850,000 | -26.0% | 82,888 | -27.2% | 0.00% | 0.0% |
| Q3 2020 | $1,148,000 | +71.6% | 113,803 | +77.4% | 0.00% | 0.0% |
| Q2 2020 | $669,000 | +189.6% | 64,134 | +975.2% | 0.00% | – |
| Q1 2019 | $231,000 | -55.7% | 5,965 | -47.6% | 0.00% | – |
| Q3 2018 | $522,000 | -10.5% | 11,374 | +15.4% | 0.00% | -100.0% |
| Q2 2018 | $583,000 | -12.5% | 9,854 | +0.6% | 0.00% | 0.0% |
| Q1 2018 | $666,000 | -31.3% | 9,796 | -0.1% | 0.00% | 0.0% |
| Q4 2017 | $969,000 | +81.5% | 9,801 | +119.9% | 0.00% | 0.0% |
| Q3 2017 | $534,000 | +16.1% | 4,457 | -15.2% | 0.00% | – |
| Q2 2017 | $460,000 | +55.9% | 5,258 | +19.6% | 0.00% | – |
| Q3 2016 | $295,000 | -17.6% | 4,395 | -3.6% | 0.00% | -100.0% |
| Q4 2015 | $358,000 | +5.3% | 4,560 | +1.0% | 0.00% | 0.0% |
| Q3 2015 | $340,000 | -84.3% | 4,513 | -75.7% | 0.00% | -66.7% |
| Q2 2015 | $2,172,000 | -56.7% | 18,600 | -12.4% | 0.00% | -57.1% |
| Q1 2015 | $5,011,000 | +29.0% | 21,221 | +3.4% | 0.01% | +16.7% |
| Q4 2014 | $3,886,000 | -22.0% | 20,529 | -1.8% | 0.01% | -25.0% |
| Q3 2014 | $4,985,000 | +1655.3% | 20,898 | +386.2% | 0.01% | – |
| Q2 2014 | $284,000 | -55.7% | 4,298 | -30.1% | 0.00% | -100.0% |
| Q1 2014 | $641,000 | -0.2% | 6,153 | -0.8% | 0.00% | 0.0% |
| Q4 2013 | $642,000 | +96.3% | 6,205 | +1.7% | 0.00% | 0.0% |
| Q3 2013 | $327,000 | +13.5% | 6,100 | -6.2% | 0.00% | 0.0% |
| Q2 2013 | $288,000 | – | 6,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |